Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCV-S vs Shanchol in healthy Nepalese participants
NCT04760236Phase 3Completed
- Sponsor
- International Vaccine Institute
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of cholera vaccine (inactivated, oral) in cholera, sponsored by International Vaccine Institute. Started Oct 2021; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT04760236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04760236.